Treatment with quercetin also decreased lymphoid enhancer-binding factor-1 (Lef1) in docetaxel-resistant breast cancer cells and re-sensitized these cells to docetaxel, acting synergistically to reduce the viability of the drug-resistant cells [415]. This evidence concerns the gene LEF1 and breast carcinoma.